Us Bancorp \De\ Vericel Corp Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Vericel Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 3,069 shares of VCEL stock, worth $173,981. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,069

Previous 4,907 37.46%

Holding current value

$173,981

Previous $225,000 42.67%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$42.25 - $53.56 $77,655 - $98,443	-1,838 Reduced 37.46%	3,069 $129,000
Q2 2024 Aug 06, 2024	BUY	$41.71 - $52.9 $117,914 - $149,548	2,827 Added 135.91%	4,907 $225,000
Q1 2024 May 07, 2024	SELL	$32.52 - $52.33 $1,821 - $2,930	-56 Reduced 2.62%	2,080 $108,000
Q4 2023 Feb 09, 2024	SELL	$30.85 - $37.09 $61 - $74	-2 Reduced 0.09%	2,136 $76,000
Q3 2023 Nov 03, 2023	SELL	$31.69 - $39.25 $3,042 - $3,768	-96 Reduced 4.3%	2,138 $71,000
Q2 2023 Aug 09, 2023	SELL	$29.0 - $38.37 $1,131 - $1,496	-39 Reduced 1.72%	2,234 $83,000
Q1 2023 May 09, 2023	BUY	$23.85 - $31.34 $13,022 - $17,111	546 Added 31.62%	2,273 $66,000
Q4 2022 Feb 13, 2023	SELL	$17.65 - $27.37 $83,590 - $129,624	-4,736 Reduced 73.28%	1,727 $45,000
Q3 2022 Oct 27, 2022	BUY	$22.62 - $32.54 $4,026 - $5,792	178 Added 2.83%	6,463 $149,000
Q2 2022 Aug 01, 2022	BUY	$22.88 - $39.45 $2,310 - $3,984	101 Added 1.63%	6,285 $159,000
Q1 2022 May 11, 2022	BUY	$31.69 - $43.29 $167,988 - $229,480	5,301 Added 600.34%	6,184 $236,000
Q4 2021 Feb 11, 2022	SELL	$35.2 - $52.6 $291,843 - $436,106	-8,291 Reduced 90.37%	883 $35,000
Q3 2021 Nov 10, 2021	BUY	$46.35 - $59.75 $309,339 - $398,771	6,674 Added 266.96%	9,174 $448,000
Q2 2021 Aug 05, 2021	BUY	$47.2 - $67.81 $100,111 - $143,825	2,121 Added 559.63%	2,500 $131,000
Q1 2021 Apr 28, 2021	SELL	$30.93 - $59.48 $5,443 - $10,468	-176 Reduced 31.71%	379 $21,000
Q2 2019 Aug 13, 2019	SELL	$15.01 - $18.89 $20,713 - $26,068	-1,380 Reduced 71.32%	555 $10,000
Q3 2018 Nov 01, 2018	BUY	$9.1 - $14.8 $7,052 - $11,470	775 Added 66.81%	1,935 $27,000
Q2 2018 Aug 08, 2018	SELL	$9.6 - $14.6 $1,632 - $2,482	-170 Reduced 12.78%	1,160 $11,000
Q4 2017 Feb 02, 2018	BUY	$3.65 - $5.98 $4,854 - $7,953	1,330	1,330 $7,000

Others Institutions Holding VCEL

# of Institutions

277

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account